Results 131 to 140 of about 41,075 (183)

Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine. [PDF]

Br J Haematol
Ortega-Francisco S, Prudente de Aquino MT, La Rosa C, Chiuppesi F, Gutierrez MA, Miller J, Li J, Mack-Onyeike J, Zhou Y, Zhou Q, Kaltcheva T, Patterson A, Dempsey S, Thomas S, Tiemann K, Yang D, Rida W, Wussow F, McKee K, Taplitz R, Raiden E, Siddiqi T, Rosen S, Diamond DJ, Danilov A.   +24 more
europepmc   +1 more source

Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico. [PDF]

Hematol Transfus Cell Ther
Salazar-Riojas R, Alvarado-Navarro DM, Ruiz-de la Cruz ML, Castro-Fuentes LN, Vazquez-Hernandez KE, Gomez-Almaguer D, Rosas-Taraco AG.   +6 more
europepmc   +1 more source

Acute Kidney Injury Following Vaccine-Induced Thrombotic Microangiopathy. [PDF]

Eur J Case Rep Intern Med
Aabideen M, Vellanki VS, Tungekar MF.
europepmc   +1 more source

Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2-naïve individuals. [PDF]

Eur J Microbiol Immunol (Bp)
Méndez Rodríguez ML, Ponciano-Gómez A, Campos-Aguilar M, Tapia-Sánchez WD, Duarte-Martínez CL, Romero-Herrera JS, Olivas-Quintero S, Saucedo-Campos AD, Lopez-Sanchez JI, Méndez-Cruz AR, Jiménez-Flores R, Romero-Ramírez H, Santos-Argumedo L, Rosales-García VH, Ortiz-Navarrete V.   +14 more
europepmc   +1 more source

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses. [PDF]

mSphere
Wangteeraprasert A, Pongcharoen S, Ngoenkam J, Makanut S.   +3 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of the Incidence of Myocarditis and Guillain-Barré Syndrome in Adolescents Receiving COVID-19 mRNA Vaccine. [PDF]

Cureus
Kumar C, Akhileshwar, Kumar Neeraj R, Hameed S, Husain N, Roy SS, Mohan L, Anantsaznam.   +7 more
europepmc   +1 more source

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial. [PDF]

Vaccines (Basel)
Putri ND, Zhafira AS, Wicaksana P, Satari HI, Fadlyana E, Safitri V, Nurlailah N, Putri ES, Putri N, Iriyani DS, Ulina YS, Aprilia F, Pratama E, Nethalia I, Yustisiana R, Aini EQ, Fajarani R, Susilo A, Karyanti MR, Prayitno A, Sukandar H, Watts E, Mazarakis N, Multihartina P, Setiawaty V, Pangesti KNA, Indrati AR, Sundoro J, Handayani DO, Kartasasmita CB, Hadinegoro SR, Mulholland K.   +31 more
europepmc   +1 more source

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines. [PDF]

Nat Commun
Chen W, Tompkins KR, Windsor IW, Martinez LT, Ramos M, Li W, Shrivastava S, Rajput S, Chang JS, Sahasrabudhe P, Fennell KF, McLellan TJ, West GM, Dizon KP, Yam A, Mitra S, Saha S, Sharaf D, McKeen AP, Cadima CI, Muik A, Swanson W, Munoz Moreno R, Mendoza Daroca P, Sahin U, Anderson AS, Wu H, Swanson KA, Modjarrad K.   +28 more
europepmc   +1 more source

COVID-19 Vaccination Strategy and Evidence in Korea. [PDF]

J Korean Med Sci
Hwang YH, Park WB.
europepmc   +1 more source

T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children. [PDF]

Open Forum Infect Dis
Vogler I, Renken S, Hilker R, Lui BG, Finlayson A, Gurtman A, Sabharwal C, Kitchin N, Lockhart S, Gruber WC, Jansen KU, Swanson KA, Türeci Ö, Şahin U.   +13 more
europepmc   +1 more source